venBio Partners LLC
- SEC CIK
- 0001776382
- Latest filing
- Aug 14, 2026
Holdings in Q4 2025
Holdings as of Dec 31, 2025, filed Feb 17, 2026. Long positions only; changes compare share counts with Q3 2025.
- Positions
- 6
- 0 vs. Q3 2025
- Portfolio value
- $216.3M
- +$39.9M (+22.6%) vs. Q3 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PHVSPharvaris N.V. | COM | 4,639,304 | $128.7M | 59.5% | 00.0% | Unchanged | History |
| ALMSAlumis Inc. | COM | 4,619,803 | $45.1M | 20.8% | 00.0% | Unchanged | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 489,194 | $18.3M | 8.5% | 00.0% | Unchanged | History |
| ALXOAlx Oncology Holdings Inc | COM | 9,699,925 | $11.0M | 5.1% | 00.0% | Unchanged | History |
| LYELLyell Immunopharma, Inc. | COM NEW | 337,697 | $10.4M | 4.8% | −135,782−28.7% | Reduced | History |
| ARTVArtiva Biotherapeutics, Inc. | COM | 648,507 | $2.78M | 1.3% | −500,468−43.6% | Reduced | History |